Sigmoid Pharma

18 results

The Irish Times Innovation Awards 2018

From life-saving drugs and med-tech devices to trout caviar and easy-cook vegetables, from flat-pack air-conditioning ducts to high-tech chips for sat(...)

Stage at The Irish Times InterTradeIreland Innovation Awards 2012, at the Royal Hospital Kilmainham. Photograph: Dara Mac Dónaill

An anti-microbial coating that kills more than 99 per cent of harmful bacteria and superbugs; an ingenious and cost-efficient manufacturing and assemb(...)

Ireland’s largest estate agent Sherry FitzGerald paid a dividend of just more than over €1 million to shareholders last year

Ireland’s largest estate agent Sherry FitzGerald paid a dividend of just more than over ¤1 million to shareholders last year on the back of strong sal(...)

Alex Hobbs, chairman and Sarah-Jane Larkin, director general, Irish Venture Capital Association. The IVCA has urged the Government to act following weak investment figures. Photograph: Colm Mahady/Fennell Photography

Venture capital funding into Irish tech firms fell by 9 per cent in the first half of 2018, the first time that the funding has fallen since 2011. Th(...)

Dr Albert Agro, chief executive of Sublimity Therapeutics.

Irish-founded pharma company Sublimity Therapeutics, which closed a $64 million (€55 million) round in May, has said it will need to raise “significan(...)

 Sublimity’s chief technology officer Ivan Coulter

Irish-founded pharma company Sublimity Therapeutics is considering a potential flotation as it looks to get its flagship solution to market within the(...)

 Ivan Coulter, chief executive of Sigmoid Pharma.

Irish pharma company Sublimity Therapeutics (formerly Sigmoid Pharma), has closed a $64 million (€54.7 million) financing round to fund the developmen(...)

Invent DCU  was set up in 2001 to forge better links between researchers and industry

Dublin City University’s innovation campus is looking to significantly expand and is also in talks about a private-public partnership (PPP) to create (...)

 Ivan Coulter from Sigmoid Pharma: Its deal with Dr Falk Pharma is reported to be worth more thna €100m. Photograph: Alan Betson

With Brexit centre stage, there is a temptation for all attention in Ireland to focus on two topics: how much the move might damage our economy; and w(...)

Sigmoid chief executive Ivan Coulter highlights the ‘very powerful validation’ the involvement of Dr Falk Pharma brings Sigmoid.

Speciality drug group Sigmoid Pharma has signed a landmark partnership with one of the biggest players in gastrointestinal therapy. The deal with fami(...)

  • 1
  • 2
  • Next
  • Last »